PTK2 and neoplasm: Meanwhile, COL1A2 chain binding with integrin αvβ8 promotes EMT by activating the FAK/mitogen-activated protein kinase (MEK)/ERK signaling pathway, leading to higher tumor cell aggressiveness in OSCC [126].